Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Alnylam
Alnylam
Alnylam's potential fourth RNAi approval delayed three months, but impact likely to be 'modest'
Endpoints
Mon, 04/4/22 - 11:08 pm
Alnylam
RNAi
FDA
vutrisiran
The biggest launches of 2022: a reboot
EP Vantage
Mon, 02/14/22 - 10:48 am
drug launches
Eli Lilly
tirzepatide
Alnylam
vutrisiran
Roche
Vabysmo
JNJ
Carvykti
Mirati Therapeutics
adagrasib
Bristol Myers Squibb
mavacamten
deucravacitinib
SFNP 2022 – Alnylam takes heart from its Onpattro follow-on
EP Vantage
Tue, 01/25/22 - 10:41 am
Alnylam
vutrisiran
Onpattro
hereditary ATTR amyloidosis
Alnylam, awaiting key study data, builds case for its next rare disease drug
BioPharma Dive
Sat, 01/22/22 - 02:12 pm
Alnylam
ATTR
vutrisiran
7 drugs likely to hit $1B in annual revenue in the next 5 years
Beckers Hospital Review
Thu, 01/13/22 - 07:31 am
FDA
adagrasib
donanemab
faricimab
lecanemab
tezepelumab
tirzepatide
vutrisiran
Eli Lilly
Mirati Therapeutics
Roche
Chugai
Eisai
Biogen
AstraZeneca
Amgen
Alnylam
Where will Novartis spend the $21B from Roche stake sale? Alnylam buyout could be one: report
Fierce Pharma
Thu, 11/18/21 - 10:50 am
Novartis
Roche
M&A
Alnylam
What Novartis could buy with its windfall
EP Vantage
Fri, 11/5/21 - 09:40 am
Novartis
M&A
Roche
Sandoz
Aurinia Pharmaceuticals
Alnylam
Exelixis
Incyte
Eisai
Genmab
Alnylam Announces Planned CEO Leadership Transition
Yahoo Finance
Thu, 10/28/21 - 10:42 am
Alnylam
earnings
Pharma CEOs
John Maraganore
Dicerna can’t catch up with Alnylam
EP Vantage
Mon, 08/9/21 - 10:50 am
Dicerna
Primary Hyperoxaluria
Alnylam
nedosiran
Alnylam's Study on Renal Treatment Shows Promising Results In Phase III Trial
BioSpace
Mon, 08/2/21 - 11:06 am
Alnylam
RNAi
renal decline
clinical trials
lumasiran
A 'springboard' to the future: Genentech, Sanofi and Alnylam execs sound off on pharma's evolving back-to-work plans
Fierce Pharma
Wed, 05/26/21 - 12:05 am
pandemic
COVID-19
Genentech
Sanofi
Alnylam
remote work
human resources
The "Rare Disease Company Coalition" Launches to Share the Unique Challenges and Promise of Rare Disease Therapy Development to Support Continued Progress and Patient Access
Yahoo/Businesswire
Thu, 05/13/21 - 12:04 pm
Rare Diseases
Rare Disease Company Coalition
drug development
drug discovery
Acceleron
Aeglea BioTherapeutics
Agios Pharmaceuticals
Alnylam
Harmony Biosciences
Orchard Therapeutics
Orphazyme
Sarepta Therapeutics
Taysha Gene Therapies
Ultragenyx
Alnylam provides long-term look at Oxlumo, aiming to further carve out stake in PH1 market
Endpoints
Tue, 05/4/21 - 10:38 am
Alnylam
Oxlumo
Primary Hyperoxaluria
clinical trials
AAN 2021 – Helios backs Alnylam’s sunny forecasts
EP Vantage
Wed, 04/21/21 - 10:28 am
Alnylam
AAN
vutrisiran
Onpattro
hATTR amyloidosis
Alnylam CEO Maraganore scored $7.8M in 2020 pay. Or was it $13.6M? Depends how you view the numbers
Fierce Pharma
Thu, 04/15/21 - 11:59 pm
John Maraganore
Alnylam
Pharma CEOs
executive pay
Biotech’s important clinical data readouts
EP Vantage
Fri, 03/26/21 - 10:35 am
biotech
Scholar Rock
apitegromab
spinal muscular atrophy
Alnylam
vutrisiran
Dicerna
nedosiran
Primary Hyperoxaluria
FDA
John Maraganore makes a bold promise ahead of #JPM21 — aiming to take Alnylam into the ranks of biotech's best
Endpoints
Mon, 01/11/21 - 10:41 am
Alnylam
Pharma CEOs
John Maraganore
JPMHC 2021
Alnylam's next-gen ATTR amyloidosis drug hits goals in phase 3, teeing up approval filing
Fierce Biotech
Thu, 01/7/21 - 11:33 am
clinical trials
Alnylam
ATTR amyloidosis
vutrisiran
FDA approves Alnylam's first-ever drug for rare kidney disease
Bizjournals
Tue, 11/24/20 - 10:41 am
Alnylam
FDA
kidney disease
Primary Hyperoxaluria
Decibel Therapeutics raises $82M as Laurence Reid looks to steer gene therapy pivot
Endpoints
Mon, 11/9/20 - 10:57 am
Decibel Therapeutics
Alnylam
Millennium
gene therapy
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »